Navigation Links
Abveris and Geneious Biologics Collaborate to Advance Antibody NGS Data Analysis
Date:6/11/2019

With a rapidly growing customer base and a wide range of antibody discovery services, Abveris plans to leverage the Geneious Biologics platform as a premium hub for bioinformatics and computer programming capabilities.

Dr. Colby Souders, Chief Technology Officer at Abveris, says: “The Geneious team has done an excellent job accommodating our specific data, resulting in a streamlined, high-throughput workflow that produces accurate data and operates efficiently without the need to integrate multiple bioinformatics platforms. We look forward to continuously improving the platform and its integration into our workflow to combine sequence analytics with metadata and assay data to accelerate candidate selection.”

The Geneious team worked closely with Abveris to optimize and enhance the handling of their antibody NGS data. Jannick Bendtsen, VP Technology Services at Geneious, says: “Abveris is at the cutting edge of antibody drug discovery; they are pushing the boundaries of science and technology. To have Colby and the team select Geneious Biologics is a great honor and a great compliment. We collaborated to integrate our Single Clone Antibody Annotator Pipeline and it now runs out of the box. It’s all about speed and accuracy in the discovery process.”

About Abveris
Abveris is a premium Boston-area contract research organization specializing in antibody discovery. Abveris partners with large and small biopharmaceutical companies to discover novel therapeutic products and critical reagent antibodies using diverse platforms, including the proprietary DiversimAb™ hyperimmune mouse technology and a variety of humanized mice. Additional information about Abveris is available at http://www.abveris.com.

About Geneious and Biomatters
Biomatters empowers its customers with software that transforms biological data into knowledge and actionable insights across the spectrum of biotechnology research and development, including drug discovery, protein engineering and advanced comparative analysis of DNA, RNA and protein sequences. Geneious solutions are created from a deep understanding of customer experience and turn the difficult into the intuitive and easy. That is why Geneious is trusted by over 4,000 companies, universities and institutes all over the globe. http://www.geneious.com

Read the full story at https://www.prweb.com/releases/abveris_and_geneious_biologics_collaborate_to_advance_antibody_ngs_data_analysis/prweb16370725.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Geneious Supports the Transition from Vector NTI
2. Catalent to Launch OneBio Suite for Integrated Biologics Development, Manufacturing and Supply at BIO International 2019
3. 3Bar Biologics and Pivot Bio Help Farmers Increase Crop Productivity and Decrease Need for Fertilizer
4. Royal Biologics Launches Maxx-Cell, the World's Most Advanced Bone Marrow Aspiration Device
5. Dovel Technologies Awarded Biologics Surveillance IDIQ
6. Genedata Announces Aptevo Therapeutics Deploys Genedata Biologics to Streamline Cancer Immunotherapy R&D
7. AcCELLerated Biologics announces strategic partnership with Exceleron Media.
8. Mosaic Biomedicals se une a Northern Biologics
9. Synthetic Biologics Announces Pricing of Public Offering of Common Stock and Warrants
10. Next-Generation Biologics: R&D, Industry and Market Forecasts 2015-2025
11. MassBiologics receives orphan drug status from FDA for hepatitis C treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2019)... ... May 24, 2019 , ... Zolgensma (Novartis, AveXis), an AAV-delivered gene therapy ... clinical use in the United States by the Food and Drug Administration today. ... treat inherited genetic disorders in the United States and the second-ever approved treatment for ...
(Date:5/23/2019)... ... ... Federal Publications Seminars, the leading provider of government contracts training and professional ... 2.0, an updated version of its FPSOnline platform. , Attendees of ... Week, were given a “sneak peek” of FPSOnline 2.0 during the conference and response ...
(Date:5/23/2019)... ... May 23, 2019 , ... Inference Solutions , ... organizations, today announced its inclusion in DMG Consulting’s 2019-2020 Intelligent Virtual Agent Product ... (IVA) market share leader, based on number of customers, with 15.8% share of ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ... June 10, 2019 , ... Thought Technology ... the appointment of Biofeedback Tech Ltd as its authorised distributor for ... part of many therapeutic treatments and clinical assessment protocols to treat stress related ...
(Date:6/11/2019)... Calif. (PRWEB) , ... June 11, 2019 , ... ... company of Personalized Stem Cells Inc. (PSC) , has announced that their ... Public Health, Food and Drug Branch for manufacturing. This is an important ...
(Date:5/31/2019)... ... May 29, 2019 , ... ... from the USPTO providing proprietary interest to our methodology, processes, and diagnostic ... DIAGNOSIS AND TREATMENT… extends Somnology’s IP rights including our proprietary sleep scoring ...
(Date:5/22/2019)... NEW YORK (PRWEB) , ... May 22, 2019 , ... ... it has closed a $8 million Series A funding round co-led by Astanor ... State’s Empire State Development Fund and iSelect Fund . The company ...
Breaking Biology Technology: